Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen

被引:9
作者
Kontos, M. [1 ]
Allen, D. S. [1 ]
Agbaje, O. F. [1 ]
Hamed, H. [1 ]
Fentiman, I. S. [1 ]
机构
[1] Guys Hosp, Hedley Atkins Breast Unit, London SE1 9RT, England
来源
EJSO | 2011年 / 37卷 / 12期
关键词
Breast cancer; Older patients; Tamoxifen; Loco-regional relapse; Randomised trial; RANDOMIZED CLINICAL-TRIAL; LOCOREGIONAL RECURRENCE; POSTMENOPAUSAL WOMEN; FOLLOW-UP; INTRAOPERATIVE RADIOTHERAPY; SURGICAL MARGINS; PLUS TAMOXIFEN; THERAPY; SURVIVAL; CONSERVATION;
D O I
10.1016/j.ejso.2011.07.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background: In breast cancer patients (>= 70 years), tumour resection plus tamoxifen (T T) has a higher loco-regional relapse (LR) rate than mastectomy. This study examines factors influencing local recurrence in these cases. Methods: Clinical records of 71 patients aged >= 70 years, randomised to the T + T arm of 2 randomised trials were reviewed. Cox Proportional Hazards model was used to determine the most significant variables. Results: After 15-years follow-up, LR relapse occurred in 29/71, of whom 5 had synchronous metastatic disease. Most tumours recurred in the index quadrant. Subsequently 21/24 patients with loco-regional recurrence only had salvage mastectomy. Three variables significantly predicted LR: lympho-vascular invasion (LVI) (FIR [95% CI]: 11.18 [4.47, 27.95], p < 0.01), ER negative status (HR [95% CI]: 0.27 [0.10, 0.72] p = 0.01), and tumour necrosis (HR [95% CI]: 2.65 [1.10, 6.37], p = 0.03). Final margin status was not associated with LR. Conclusions: Tumour resection + Tamoxifen in older patients results in long-term local control in the majority with most loco-regional failures being salvageable. Risk factors for LR are lympho-vascular invasion, ER status and tumour necrosis. Negative tumour excision margins did not significantly change local outcome in the absence of radiotherapy. In these older patients LVI significantly reduced survival time. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1051 / 1058
页数:8
相关论文
共 33 条
[1]
Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy [J].
Assersohn, L ;
Powles, TJ ;
Ashley, S ;
Nash, AG ;
Neal, AJ ;
Sacks, N ;
Chang, J ;
della Rovere, UQ ;
Naziri, N .
ANNALS OF ONCOLOGY, 1999, 10 (12) :1451-1455
[2]
Factors associated with surgical and radiation therapy for early stage breast cancer in older women [J].
BallardBarbash, R ;
Potosky, AL ;
Harlan, LC ;
Nayfield, SG ;
Kessler, LG .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (11) :716-726
[3]
Baum M, 2002, LANCET, V359, P2131
[4]
Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study [J].
Briot, Karine ;
Tubiana-Hulin, Michele ;
Bastit, Laurent ;
Kloos, Ioana ;
Roux, Christian .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (01) :127-134
[5]
A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer-Final results at 20-year follow-up [J].
Chakrabarti, J. ;
Kenny, F. S. ;
Syed, B. M. ;
Robertson, J. F. R. ;
Blamey, R. W. ;
Cheung, K. L. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 (03) :260-264
[6]
Recent trends in US breast cancer incidence, survival, and mortality rates [J].
Chu, KC ;
Tarone, RE ;
Kessler, LG ;
Ries, LAG ;
Hankey, BF ;
Miller, BA ;
Edwards, BK .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21) :1571-1579
[7]
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer [J].
Coombes, RC ;
Hall, E ;
Gibson, LJ ;
Paridaens, R ;
Jassem, J ;
Delozier, T ;
Jones, SE ;
Alvarez, I ;
Bertelli, G ;
Ortmann, O ;
Coates, AS ;
Bajetta, E ;
Dodwell, D ;
Coleman, RE ;
Fallowfield, LJ ;
Mickiewicz, E ;
Andersen, J ;
Lonning, PE ;
Cocconi, G ;
Stewart, A ;
Stuart, N ;
Snowdon, CF ;
Carpentieri, M ;
Massimini, G ;
Bliss, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11) :1081-1092
[8]
Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial [J].
de Haes, JCJM ;
Curran, D ;
Aaronson, NK ;
Fentiman, IS .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (07) :945-951
[9]
Radiotherapy after lumpectomy for breast cancer in very old women [J].
Deutsch, M .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (01) :48-49
[10]
Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer [J].
Fennessy, M ;
Bates, T ;
MacRae, K ;
Riley, D ;
Houghton, J ;
Baum, M .
BRITISH JOURNAL OF SURGERY, 2004, 91 (06) :699-704